Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€174.42
27.04.22
€190.00
27.04.23
-15.38%
27.04.23

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€233.45
25.04.22
€250.00
25.04.23
14.61%
26.04.23

Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€302.40
13.03.23
-
13.04.23
11.97%
14.04.23

Could be very worthwhile Investment >20% year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€50.65
07.04.22
€56.00
07.04.23
-24.58%
08.04.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€248.30
06.04.22
-
06.04.23
18.49%
06.04.23

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€638.60
06.04.22
-
06.04.23
17.91%
06.04.23

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€47.88
25.03.22
€64.00
25.03.23
-21.14%
27.03.23

Could be worthwhile Investment >10% per year
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€150.38
02.03.22
-
02.03.23
-4.80%
03.03.23

buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€246.90
30.01.22
€270.00
30.01.23
-9.98%
31.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€407.05
24.01.22
€418.00
24.01.23
10.66%
25.01.23

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€50.01
03.01.22
€78.00
03.01.23
-2.98%
04.01.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€301.55
28.10.22
-
28.10.23
-10.79%
01.01.23

Risky Investment
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€149.96
28.12.21
-
28.12.22
10.44%
29.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good culture
Top 10 in its market
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€208.25
27.12.21
€215.00
27.12.22
23.82%
28.12.22

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€52.51
22.12.21
€55.00
22.12.22
-7.45%
23.12.22

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.36
06.12.21
€60.00
06.12.22
-0.12%
06.12.22

Could be worthwhile Investment >10% per year
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.70
27.11.21
€160.00
27.11.22
21.35%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€533.60
09.11.21
€600.00
09.11.22
38.91%
10.11.22

Could be worthwhile Investment >10% per year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.87
15.05.22
€68.00
15.05.23
32.12%
28.10.22

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
buy
Davita Inc.

Start price
Target price
Perf. (%)
€73.02
28.10.22
-
0.45%
28.10.22

Risky Investment
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€70.76
26.10.21
€65.00
26.10.22
38.64%
27.10.22

Could be worthwhile Investment >10% per year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€62.08
13.10.22
-
-
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€56.78
04.02.22
€46.00
04.02.23
18.67%
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€199.36
07.09.22
€300.00
31.12.24
36.69%
30.09.22

Could be very worthwhile Investment >20% year
Henry Schein Inc.

Start price
Target price
Perf. (%)
€67.50
29.09.21
€65.00
29.09.22
0.87%
30.09.22

Could be worthwhile Investment >10% per year